Ann: Change of Director's Interest Notice, page-154

ASX / MEDIA RELEASE
ResApp Initiates SMARTCOUGH-C Study Evaluating Efficacy
of ResAppDx for Diagnosing Childhood Respiratory Disease

SMARTCOUGH-C builds on ResApp’s highly successful Australian paediatric clinical
study which demonstrated accurate diagnosis of pneumonia, asthma/viral wheeze,
bronchiolitis, croup and upper respiratory tract infections. Analysis of the Australian
study data is progressing well and ResApp will release enhanced results early in the
new year.